What is William Blair’s Estimate for Neogen FY2025 Earnings?

Neogen Corporation (NASDAQ:NEOG) – Equities research analysts at William Blair decreased their FY2025 earnings estimates for Neogen in a research report issued on Wednesday, June 18th. William Blair analyst B. Vazquez now anticipates that the company will post earnings of $0.29 per share for the year, down from their prior forecast of $0.31. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share. William Blair also issued estimates for Neogen’s Q4 2025 earnings at $0.07 EPS, FY2026 earnings at $0.24 EPS and FY2027 earnings at $0.29 EPS.

A number of other research analysts also recently commented on the stock. Piper Sandler lowered their price objective on shares of Neogen from $6.40 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 22nd. Guggenheim dropped their price target on shares of Neogen from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Thursday, April 10th.

Neogen Stock Up 3.4%

Shares of Neogen stock opened at $4.93 on Monday. The company has a current ratio of 3.91, a quick ratio of 2.45 and a debt-to-equity ratio of 0.33. Neogen has a 1 year low of $3.87 and a 1 year high of $18.58. The stock has a 50-day moving average price of $5.56 and a 200 day moving average price of $8.67. The company has a market cap of $1.07 billion, a P/E ratio of -2.21 and a beta of 1.84.

Neogen (NASDAQ:NEOG) last released its earnings results on Wednesday, April 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). Neogen had a negative net margin of 53.56% and a positive return on equity of 2.69%. The business had revenue of $221.00 million during the quarter, compared to analysts’ expectations of $225.27 million. During the same quarter in the previous year, the company earned $0.12 EPS. Neogen’s revenue for the quarter was down 3.4% on a year-over-year basis.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Harbour Investments Inc. acquired a new position in shares of Neogen during the 4th quarter worth about $27,000. Versant Capital Management Inc grew its stake in shares of Neogen by 1,495.4% in the first quarter. Versant Capital Management Inc now owns 3,127 shares of the company’s stock worth $27,000 after acquiring an additional 2,931 shares during the last quarter. Johnson Financial Group Inc. bought a new position in Neogen during the fourth quarter worth $43,000. Blue Trust Inc. raised its stake in Neogen by 247.6% during the 4th quarter. Blue Trust Inc. now owns 3,945 shares of the company’s stock valued at $48,000 after purchasing an additional 2,810 shares during the last quarter. Finally, Covestor Ltd boosted its holdings in Neogen by 41.4% in the 4th quarter. Covestor Ltd now owns 4,103 shares of the company’s stock valued at $50,000 after purchasing an additional 1,202 shares during the period. Institutional investors own 96.73% of the company’s stock.

Insider Activity at Neogen

In related news, CAO John Patrick Moylan purchased 10,000 shares of the stock in a transaction on Thursday, April 10th. The shares were bought at an average price of $5.07 per share, for a total transaction of $50,700.00. Following the completion of the acquisition, the chief accounting officer now directly owns 10,000 shares in the company, valued at approximately $50,700. This trade represents a ? increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Aashima Gupta acquired 16,000 shares of Neogen stock in a transaction dated Monday, May 12th. The stock was purchased at an average price of $6.25 per share, with a total value of $100,000.00. Following the completion of the purchase, the director now directly owns 21,917 shares of the company’s stock, valued at $136,981.25. The trade was a 270.41% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders bought 83,500 shares of company stock valued at $431,525. 1.13% of the stock is owned by corporate insiders.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.